Propofol is an intravenous anesthetic used to put patients to sleep for surgery, to sedate them for a procedure such as an endoscopy, or to keep them comfortable on a ventilator. It is not a federally scheduled controlled substance, it is cleared from the body quickly, and it is not included on any standard employer drug test panel, whether that panel is a urine cup, an oral fluid swab, or a laboratory based screen. The short answer is no, a routine workplace drug test is not designed to look for propofol and will not report it. The longer answer involves what panels actually screen for, what else a patient may receive alongside propofol during a procedure, and how a medical review officer handles a test taken soon after surgery.
What Propofol Is and How It Is Given
Propofol injectable emulsion is indicated for induction and maintenance of general anesthesia, for sedation during monitored procedures, and for sedation of intubated patients in intensive care, according to the prescribing information filed with the FDA's Drugs@FDA database record and with the National Library of Medicine. It is given only by or under the supervision of a person trained in general anesthesia administration, by intravenous injection or infusion, in a clinical setting such as an operating room, procedure suite, or intensive care unit.
The drug acts quickly and is metabolized and cleared from the bloodstream rapidly once the infusion stops, which is part of why it is useful for same day procedures. That same pharmacology, a short acting sedative hypnotic that is not chemically related to any of the drug classes a workplace panel screens for, is the main reason it has no place on a standard drug test menu. Full label details, including how the drug is classified and administered, are published by the manufacturer through DailyMed, the National Library of Medicine's drug label repository.
Why Standard Panels Are Not Built to Catch Propofol
A typical workplace urine or oral fluid screen uses an immunoassay, a chemical test that reacts to a specific drug class based on molecular shape. A plain language overview of how that screen to confirmation process works, and which drug classes a routine panel is built around, is published by the National Library of Medicine's MedlinePlus drug testing page. The classes covered by the most common federal style panel are marijuana metabolite, cocaine metabolite, opiates, phencyclidine, and amphetamines, with many employer panels adding benzodiazepines, barbiturates, and a few other classes. Background on which classes a federally modeled program screens for is published by the Substance Abuse and Mental Health Services Administration's Drug-Free Workplace Program background page, which also traces the Mandatory Guidelines for Federal Workplace Drug Testing Programs that most private panels are modeled on.
Propofol is a substituted phenol, structurally unrelated to any of those target classes. There is no credible cross reactivity evidence published showing that propofol triggers a positive result on a marijuana, opiate, amphetamine, cocaine, PCP, or benzodiazepine immunoassay, and it is not an analyte that laboratories add to standard confirmatory testing menus either. In practical terms, a cup or dip card manufactured for pre employment or random workplace screening, such as the ones described on the drug test cup collection, is simply not formulated to detect it, and ordering a specialized send out test for propofol itself is uncommon outside of hospital toxicology or research settings.
What Can Actually Show Positive After a Procedure
The more realistic question after surgery is not about propofol, it is about everything else the patient received at the same time. Anesthesia care rarely involves a single drug. Along with propofol, a patient may be given a fast acting opioid for pain control, a benzodiazepine for amnesia and anxiety reduction, or a dissociative agent for certain procedures. Those medications, unlike propofol, do overlap with panels that employers use.
Fentanyl is a common example. It is a synthetic opioid used widely in anesthesia and acute pain management, and its classification and use are described in the manufacturer labeling available through DailyMed's fentanyl citrate injection label. Many basic opiate immunoassays were originally built around natural opiates such as morphine and codeine and are not guaranteed to flag a synthetic opioid unless the laboratory has added an expanded opioid analyte or a dedicated fentanyl test. Coverage varies by lab and by panel, so a donor or employer who needs certainty should ask the laboratory directly which analytes a given panel includes rather than assume either way.
Benzodiazepines used during sedation, such as midazolam, belong to a drug class that many panels do screen for, but individual benzodiazepines cross react with a given immunoassay to very different degrees depending on the specific chemistry of the drug and the assay's cutoff. A benzodiazepine given during a procedure can register on some screens and not on others. For any case involving a recent medical procedure, confirmatory testing by gas chromatography mass spectrometry or liquid chromatography mass spectrometry is what identifies the exact substance present, rather than relying on the initial immunoassay alone.
Screening Immunoassay vs Laboratory Confirmation
It helps to separate the two steps in a typical drug test. The first step is an immunoassay screen, a fast, inexpensive method that flags a presumptive result for a drug class. The second step, used when a screen comes back non negative, is confirmation by GC/MS or LC/MS, which identifies the specific molecule rather than a class. Confirmation is what distinguishes, for example, a legitimate opioid given in a hospital from an unrelated substance, and it is also the step that would show that propofol itself was never part of the test to begin with, since it was never a target analyte on the ordered panel.
How the Medical Review Officer Handles a Post Surgical Case
When a donor tests positive for a substance that overlaps with a legitimate medical procedure, the case goes through medical review officer review rather than an automatic report to the employer. The MRO is a licensed physician trained to review laboratory results, contact the donor confidentially, and determine whether there is a legitimate medical explanation such as a documented prescription or a hospital anesthesia record. Background on the structure of federally modeled workplace testing programs, including the role of medical review, is maintained by SAMHSA's Division of Workplace Programs on the same Drug-Free Workplace Program resource. A separate explanation of how that review conversation works in practice is covered in our own article on the medical review officer process.
Donors who have had a recent surgery or procedure should keep discharge paperwork or an anesthesia record available and be prepared to share it with the MRO, not with a supervisor or coworker. This article does not provide medical advice about dosing, treatment, or how to interpret an individual lab result. Anyone with questions about a specific medication or a specific test result should direct those questions to the MRO or to their treating clinician.
Common Surgery and Procedure Drugs vs Standard Panels
| Drug | Drug class | On a standard 5 or 10 panel | Notes |
|---|---|---|---|
| Propofol | Sedative hypnotic (substituted phenol) | No | Not a target analyte on immunoassay or routine confirmatory panels; no published cross reactivity with other drug classes |
| Fentanyl | Synthetic opioid | Varies by lab | Basic opiate immunoassays built around morphine and codeine may miss it; needs an expanded opioid or fentanyl specific analyte |
| Midazolam | Benzodiazepine | Varies by assay | Benzodiazepine class is commonly screened, but individual drugs cross react unevenly; confirmation testing identifies the specific agent |
| Ketamine | Dissociative anesthetic | No, unless a dedicated ketamine test is ordered | Not part of standard employer panels; detection requires a specific ketamine analyte at a laboratory, similar to how some newer substances need their own dedicated strip or assay |
What This Means for Employers and Donors
For an employer running a drug free workplace program, the practical takeaway is that a hospital procedure involving propofol is not, by itself, a reason to expect a workplace screen to flag anything. If a positive result does occur after a documented procedure, it is almost certainly related to an opioid, a benzodiazepine, or another class the panel actually targets, and it belongs in the MRO review process rather than in an informal conversation with a supervisor. Employers who want a program that distinguishes a presumptive screen from a confirmed result should make sure their collection sites and laboratories use a verified screen to confirmation workflow, and should rely on their MRO for any case tied to recent medical care.
Frequently asked questions
Does propofol show up on a routine workplace drug test?
No. Propofol is not a target analyte on standard immunoassay panels or on the confirmatory tests laboratories typically run, and there is no published evidence that it cross reacts with the drug classes those panels screen for.
Can anesthesia from surgery cause a positive drug test?
Propofol itself generally will not. Other medications given during the same procedure, such as an opioid or a benzodiazepine, can overlap with panel drug classes and may produce a presumptive positive that should be reviewed against documented medical records.
Will fentanyl given during a procedure show up on a workplace drug test?
It depends on the panel. Basic opiate immunoassays built around morphine and codeine are not guaranteed to detect a synthetic opioid like fentanyl unless the laboratory includes an expanded opioid or fentanyl specific analyte. Ask the laboratory which analytes a given panel covers.
What should someone do if they are drug tested soon after surgery?
Keep discharge paperwork or an anesthesia record available and provide it to the medical review officer if contacted about a test result. The MRO, not a supervisor or coworker, is the appropriate point of contact for documenting a legitimate medical explanation.
Does a drug test lab specifically screen for propofol?
Not on a standard panel. Laboratories can run specialized tests for specific drugs in certain clinical or research settings, but that is not part of a routine employment or regulatory drug test menu.
This article is general information about drug testing science and panel design, not medical or legal advice. Anyone with questions about a specific medication, procedure, or test result should talk to their physician, their medical review officer, or qualified legal counsel.
